Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Total Knee Arthroplasty
NCT06470100Phase 4Completed
- Sponsor
- Poznan University of Medical Sciences
- Start
- Aug 2024
- Primary completion
- Mar 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of dexamethasone, dexmedetomidine in knee osteoarthritis (OA), Chronic knee pain, sponsored by Poznan University of Medical Sciences. Started Aug 2024; status: completed.
02
Drugs
dexamethasonedexmedetomidine
03
Conditions
knee osteoarthritis (OA)Chronic knee pain
Beyond the preview
Go deeper on NCT06470100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06470100.